Complexity in Asthma: Inflammation and Scale-Free Networks;La complejidad en el asma: inflamación y redes libres de escala

Archivos de Bronconeumologia

Volumn 45, Issue 9, 2009, Pages 459-465

  Perpiñá Tordera, Miguel ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Asthma; Inflammation; Scale free networks

Indexed keywords

ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; GENETIC POLYMORPHISM; GENOMICS; HUMAN; METABOLOMICS; NONHUMAN; PATHOGENESIS; PROTEOMICS; RESPIRATORY TRACT INFLAMMATION; VIRAL RESPIRATORY TRACT INFECTION;

ASTHMA; COMORBIDITY; COMPUTATIONAL BIOLOGY; CYTOKINES; ENDOTHELIAL CELLS; ENVIRONMENT; HUMANS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTES; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; MYELOID CELLS; NONLINEAR DYNAMICS; RESPIRATORY TRACT INFECTIONS;

EID: 67849135883     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbres.2009.03.007     Document Type: Article

References (57)

1. Bertalanffy L. Teoría general de sistemas (1976), Limusa, Madrid
2. Ruelas Barajas E., and Mansilla R. Las ciencias de la complejidad y la innovación médica (2006), Grama Editora SA, México
3. Chanez P., Wenzel S.E., Anderson G.P., Antó J.M., Bel E.H., Boulet L.P., et al. Severe asthma in adults: what are the important questions?. J Allergy Clin Immunol 119 (2007) 1337-1348
4. Sabroe I., Parker L.C., Calverley P.M.A., Doer S.K., and Whyte M.J.B. Pathological networking: a new approach to understanding COPD. Thorax 62 (2007) 733-738
5. Chung K., Godard P., Adelroth E., Ayres J., Barnes N., Barnes P., et al. Difficult/therapy resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. Eur Respir J 13 (1999) 1198-1208
6. American Thoracic Society. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 162 (2000) 2341-2351
7. ENFUMOSA Study Group. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J 22 (2003) 470-477
8. Rodríguez Trigo G., Plaza V., Picado C., and Sánchis J. El tratamiento según la guía de la Global Initiative for Asthma (GINA) reduce la morbimortalidad de los pacientes con asma de riesgo vital. Arch Bronconeumol 44 (2008) 192-196
9. Plaza V., Bolíbar J., Giner J., Llauger M.A., López Viña A., Quintano J., et al. Opinión, conocimientos y grado de seguimiento referidos por los profesionales sanitarios españoles de la Guía Española para el Manejo del Asma (GEMA). Proyecto GEMA-TEST. Arch Bronconeumol 44 (2008) 245-251
10. Morell F., Genover T., Muñoz X., García Aymerich J., Ferrer J., and Cruz M.J. Tasa y características de las agudizaciones asmáticas (ASMAB I). Arch Bronconeumol 44 (2008) 303-311
11. Martínez Moragón E., Perpiñá M., Fullana J., Macián V., Lloris A., and Belloch A. Percepción de la disnea y cumplimiento terapéutico en pacientes con asma. Arch Bronconeumol 44 (2008) 459-463
12. Bjermer L. Time for a paradigm shift in asthma treatment: from relieving bronchospasm to controlling systemic inflammation. J Allergy Clin Immunol 120 (2007) 1269-1275
13. Aamodt A.H., Stovner L.J., Langhammer A., Hagen K., and Zwart J.A. Is headache related to asthma, hay fever, and chronic bronchitis? The Head-HUNT Study. Headache 47 (2007) 204-212
14. Tollefsen E., Langhammer A., Bjermer L., Romundstat P., and Holmen T.L. Allergy: a systemic disease? The HUNT and Young-HUNT study, Norway. Pediatr Allergy Immunol 19 (2008) 730-736
15. Pavord I.D., Birring S.S., Berry M., Green R.H., Brightling C.E., and Wardlaw A.J. Multiple inflammatory hits and the pathogenesis of severe airway disease. Eur Respir J 27 (2006) 884-888
16. Cockcroft D.W., Ruffin R.E., Dolovich J., and Hargreave F.E. Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy 7 (1977) 503-513
17. Lemiere C., Malo J.L., and Gautrin D. Nonsensitizing causes of occupational asthma. Med Clin North Am 80 (1996) 749-774
18. Plaza V., Serrano J., Picado C., and Sanchis J. Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma. Eur Respir J 19 (2002) 846-852
19. Frey U., Maksym G.N., Silverman M., and Suki B. New approach to the understanding of complex chronic lung diseases. Eur Respir Mon 37 (2006) 345-360
20. Frey U. Asthma as a nonlinear complex dynamic system: a novel approach to understand the temporal behaviour of chronic asthma and its response to β-agonists. Eur Respir Rev 17 (2008) 67-69
21. Frey U., and Suki B. Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control. Lancet 372 (2008) 1088-1099
22. Barabási A.L. Linked: the new sciences of networks (2002), Perseus, Cambridge, MA
23. Albert R., and Barabási A.L. Statistical mechanics of complex networks. Rev Modern Phys 74 (2002) 47-97
24. Newman M.E.J. The structure and function of complex networks. SIAM Rev 45 (2003) 167-256
25. Boccaletti S., Latora V., Moreno Y., Chavez M., and Hwang D.U. Complex networks: structure and dynamics. Phys Rep 424 (2006) 175-308
26. Barabási A.L., and Oltvai Z.N. Network biology: understanding the cell's functional organization. Nature Rev 5 (2004) 101-113
27. Seely A.J.E., and Macklem P.T. Complex systems and the technology of variability analysis. Crit Care 8 (2004) R367-R384
28. Oikonomou P., and Cluzel P. Effects of topology on network evolution. Nature Phys 2 (2006) 532-536
29. Loscalzo J., Kohane I., and Barabási A.L. Human disease classification in the postegenomic era: a complex systems approach to human pathobiology. Mol Syst Biol 3 (2007) 124
30. Albert R. Scale-free neworks in cell biology. J Cell Biol 118 (2005) 4947-4957
31. Goh K.I., Cusick M.E., Valle D., Childs B., Vidal M., and Barabási A.L. The human disease network. Proc Natl Acad Sci USA 104 (2007) 8685-8690
32. Lee D.S., Park J., Kay K.A., Christakis N.A., Oltval Z.N., and Barabási Al. The implications of human metabolic network topology for disease comorbidity. Proc Natl Acad Sci USA 105 (2008) 9880-9885
33. Ergun A., Lawrence C.A., Kohanski M.A., Brennen T.A., and Collins J.J. A network biology approach to prostate cancer. Mol Syst Biol 3 (2007) 82
34. Pastor Satorras R., and Vespignani A. Epidemic spreading in scale free networks. Phys Rev Letts 86 (2001) 3200-3203
35. Christakis N.A., and Fowler J.H. The spread of obesity in a large social network over 32 years. N Engl J Med 357 (2007) 370-379
36. The Plos Medicine Editors. It's the network, stupid: why everything in medicine is connected. Plos Med 5 (2008) 333-334
37. Lu X., Jain V.V., Finn P.W., and Perkins D.L. Hubs in biological interaction networks exhibit low changes in expression in experimental asthma. Mol Syst Biol 3 (2007) 98
38. Hwang S., Son S.W., Kim S.C., Kim Y.J., Jeong H., and Lee D. A protein interaction network associated with asthma. J Theor Biol 252 (2008) 722-731
39. Frey U., Brodbeck T., Majumdar A., Taylor D.R., Town G.I., Silverman M., et al. Risk of sever asthma episodes predicted from fluctuation analysis of airway function. Nature 438 (2005) 667-670
40. Thomson N.C., and Spears M. The influence of smoking on the treatment response in patients with asthma. Curr Opin Allergy Clin Immunol 5 (2005) 57-63
41. Holtzman M.J., Agapoc E., Kim E., Kim J., and Morton J.D. Developing the epitelial, viral, and allergic paradigm for asthma. Chest 123 (2003) 377S-384S
42. Van Rensen E.L.J., Sont J.K., Evertse C.E., Willems L.N., Mauad T., Hiemstra P.S., et al. Bronchial CD8 cell infiltrate and lung function decline in asthma. Am J Respir Crit Care Med 172 (2005) 837-841
43. Lemanski R.J. Is asthma an infectious disease?. Chest 123 (2003) 385S-390S
44. Moorman J., Saad M., Kosseifi S., and Krishnaswamy G. Hepatitis C virus and the lung. Implications for therapy. Chest 128 (2005) 2882-2892
45. Kanazawa H., Mamoto T., Hirata K., and Yoshikawa J. Interferon therapy induces the improvement of lung function by inhaled corticosteroid therapy in asthmatic patients with chronic hepatitis C virus infection. A preliminary study. Chest 123 (2003) 600-603
46. Kanazawa H., and Yoshikawa J. Accelerated decline in lung function and impaired reversibility with salbutamol in asthmatic patients with chronic hepatitis C virus infection: a 6-year follow-up study. Am J Med 116 (2004) 749-752
47. Kanazawa H., Hirata K., and Yoshikawa J. Increased response to inhaled oxitropium bromide in asthmatic patients with active hepatitis C virus infection. Chest 125 (2004) 1368-1371
48. Kanazawa H., Hirata K., and Yoshikawa J. Accelerated decline of lung function in COPD patients with chronic hepatitis C virus infection: a preliminary study bases on small numbers of patients. Chest 123 (2003) 596-599
49. Kanazawa H., and Yoshikawa J. Alterations in T-lymphocyte subsets in the airways of asthmatic patient with active hepatitis C virus infection. Respiration 73 (2006) 318-323
50. Kubo K., Yamaguchi S., Fujimoto K., Hanaoka M., Hayasaka M., Honda T., et al. Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection. Thorax 51 (1996) 312-314
51. 2 muscarinic receptor dysfunction. Am J Respir Crit Care Med 167 (2003) 550-556
52. Sabroe I., Parker L.C., Dockrell D.H., Davies D.E., Dower S.K., and Whyte M.K.B. Targetting the networks that underpin contiguous immunity in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175 (2007) 306-311
53. Denburg J.A., and Van Eeden S.F. Bone marrow progenitors in inflammation and repair: new vistas in respiratory biology and pathophysiology. Eur Respir J 27 (2006) 441-445
54. Sabroe I., Parker L.C., Dower S.K., and Whyte M.K.B. Practical and conceptual models of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4 (2007) 606-610
55. Lemberger T. Systems biology in human health and disease. Mol Syst Biol 3 (2007) 136
56. Lusis A.J. A thematic review series: systems biology approaches to metabolic and cardiovascular disorders. J Lipid Res 47 (2006) 1887-1890
57. Solé R. Redes complejas. Del genoma a internet (2009), Tusquets Editores, Barcelona